HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence?
Crossref DOI link: https://doi.org/10.1007/s00277-014-2236-4
Published Online: 2014-11-23
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bockorny, Bruno
Dasanu, Constantin A.
Text and Data Mining valid from 2014-11-23